4‐protein signature predicting tamoxifen treatment outcome in recurrent breast cancer

Estrogen receptor (ER) positive tumors represent the majority of breast malignancies, and are effectively treated with hormonal therapies, such as tamoxifen. However, in the recurrent disease resistance to tamoxifen therapy is common and a major cause of death. In recent years, in‐depth proteome ana...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Mol Oncol
Main Authors: De Marchi, Tommaso, Liu, Ning Qing, Stingl, Cristoph, Timmermans, Mieke A., Smid, Marcel, Look, Maxime P., Tjoa, Mila, Braakman, Rene B.H., Opdam, Mark, Linn, Sabine C., Sweep, Fred C.G.J., Span, Paul N., Kliffen, Mike, Luider, Theo M., Foekens, John A., Martens, John W.M., Umar, Arzu
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2015
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528925/
https://ncbi.nlm.nih.gov/pubmed/26285647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2015.07.004
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki